Tanya Siddiqi MD
Tanya Siddiqi, M.D., is an accomplished hematologist-oncologist who specializes in diagnosing and treating blood cancers, particularly Chronic Lymphocytic Leukemia (CLL) and B-cell Non-Hodgkin Lymphoma (B-NHL). She is also a supervising physician at City of Hope's anti-coagulation clinic, which treats patient with blood clotting disorders due to their diseases or treatments.
In addition to her clinical practice, Dr. Siddiqi is also principal investigator on a number of clinical trials evaluating the role of targeted therapies, including gene therapy (CAR T cell therapy), and other novel agents primarily in diseases like CLL and B-NHL.
Dr. Siddiqi earned her medical degree at Aga Khan University Medical College in Karachi, Pakistan. Afterward, she completed an internal medicine residency at University of Connecticut Health Center, followed by fellowships in hematology/oncology at Beth Israel Deaconess Medical Center (Harvard Medical School, Boston) and hematopoietic stem cell transplantation at City of Hope.
Dr. Siddiqi is a member of the Immunotherapy Disease Team, Toni Stephenson Lymphoma Center, and the Gehr Family Center for Leukemia Research.